nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Ceftriaxone—GLUL—epilepsy syndrome	0.00421	0.84	CrCbGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00417	0.0254	CbGpPWpGaD
Ceftibuten—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00406	0.0247	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00387	0.0235	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00381	0.0232	CbGpPWpGaD
Ceftibuten—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00377	0.023	CbGpPWpGaD
Ceftibuten—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00372	0.0226	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00354	0.0215	CbGpPWpGaD
Ceftibuten—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00345	0.021	CbGpPWpGaD
Ceftibuten—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00345	0.021	CbGpPWpGaD
Ceftibuten—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00321	0.0195	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00316	0.0192	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00316	0.0192	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00301	0.0183	CbGpPWpGaD
Ceftibuten—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00294	0.0179	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00293	0.0178	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00293	0.0178	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00279	0.017	CbGpPWpGaD
Ceftibuten—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00273	0.0166	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00239	0.0146	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00239	0.0146	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00222	0.0135	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00222	0.0135	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00219	0.0133	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00203	0.0124	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00203	0.0124	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00189	0.0115	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00186	0.0113	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00186	0.0113	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00186	0.0113	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00179	0.0109	CbGpPWpGaD
Ceftibuten—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00173	0.0105	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00173	0.0105	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00173	0.0105	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00173	0.0105	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.0017	0.0104	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00166	0.0101	CbGpPWpGaD
Ceftibuten—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00161	0.00977	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00158	0.00962	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00141	0.00859	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00141	0.00859	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00141	0.00859	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.00135	0.00819	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00131	0.00797	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00131	0.00797	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00131	0.00797	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.00125	0.0076	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.0011	0.00668	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.00107	0.00651	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.00107	0.00651	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.00106	0.00646	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00106	0.00646	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.00102	0.0062	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000992	0.00604	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000992	0.00604	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000985	0.00599	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000985	0.00599	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000978	0.00595	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000946	0.00576	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000946	0.00576	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000946	0.00576	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000909	0.00553	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000907	0.00552	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000878	0.00534	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000878	0.00534	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000878	0.00534	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000865	0.00527	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000844	0.00513	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000803	0.00489	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.0008	0.00487	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000773	0.0047	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000756	0.0046	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000743	0.00452	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000717	0.00437	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000717	0.00436	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000717	0.00436	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000717	0.00436	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000702	0.00427	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000689	0.00419	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000684	0.00416	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000684	0.00416	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000665	0.00405	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000665	0.00405	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000665	0.00405	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000639	0.00389	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000635	0.00386	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000635	0.00386	CbGpPWpGaD
Ceftibuten—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.00059	0.00071	CcSEcCtD
Ceftibuten—Abdominal pain—Clonazepam—epilepsy syndrome	0.00059	0.00071	CcSEcCtD
Ceftibuten—Body temperature increased—Clonazepam—epilepsy syndrome	0.00059	0.00071	CcSEcCtD
Ceftibuten—Fatigue—Lamotrigine—epilepsy syndrome	0.000589	0.000709	CcSEcCtD
Ceftibuten—Dysgeusia—Pregabalin—epilepsy syndrome	0.000589	0.000709	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000589	0.000709	CcSEcCtD
Ceftibuten—Urticaria—Phenytoin—epilepsy syndrome	0.000589	0.000709	CcSEcCtD
Ceftibuten—Pruritus—Vigabatrin—epilepsy syndrome	0.000587	0.000707	CcSEcCtD
Ceftibuten—Asthenia—Diazepam—epilepsy syndrome	0.000586	0.000706	CcSEcCtD
Ceftibuten—Body temperature increased—Phenytoin—epilepsy syndrome	0.000586	0.000705	CcSEcCtD
Ceftibuten—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000586	0.000705	CcSEcCtD
Ceftibuten—Constipation—Lamotrigine—epilepsy syndrome	0.000585	0.000704	CcSEcCtD
Ceftibuten—Renal failure—Topiramate—epilepsy syndrome	0.000584	0.000703	CcSEcCtD
Ceftibuten—Nausea—Acetazolamide—epilepsy syndrome	0.000584	0.000703	CcSEcCtD
Ceftibuten—Dizziness—Levetiracetam—epilepsy syndrome	0.000583	0.000702	CcSEcCtD
Ceftibuten—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000583	0.000701	CcSEcCtD
Ceftibuten—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000583	0.000701	CcSEcCtD
Ceftibuten—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000582	0.000701	CcSEcCtD
Ceftibuten—Vomiting—Propofol—epilepsy syndrome	0.00058	0.000699	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000578	0.000696	CcSEcCtD
Ceftibuten—Pruritus—Diazepam—epilepsy syndrome	0.000578	0.000696	CcSEcCtD
Ceftibuten—Rash—Propofol—epilepsy syndrome	0.000576	0.000693	CcSEcCtD
Ceftibuten—Dermatitis—Propofol—epilepsy syndrome	0.000575	0.000692	CcSEcCtD
Ceftibuten—Headache—Propofol—epilepsy syndrome	0.000572	0.000689	CcSEcCtD
Ceftibuten—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00057	0.000686	CcSEcCtD
Ceftibuten—Chills—Gabapentin—epilepsy syndrome	0.000569	0.000685	CcSEcCtD
Ceftibuten—Vomiting—Midazolam—epilepsy syndrome	0.000568	0.000684	CcSEcCtD
Ceftibuten—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000568	0.000684	CcSEcCtD
Ceftibuten—Asthenia—Felbamate—epilepsy syndrome	0.000567	0.000683	CcSEcCtD
Ceftibuten—Haematuria—Topiramate—epilepsy syndrome	0.000566	0.000682	CcSEcCtD
Ceftibuten—Rash—Midazolam—epilepsy syndrome	0.000563	0.000678	CcSEcCtD
Ceftibuten—Dizziness—Fosphenytoin—epilepsy syndrome	0.000563	0.000678	CcSEcCtD
Ceftibuten—Dermatitis—Midazolam—epilepsy syndrome	0.000563	0.000677	CcSEcCtD
Ceftibuten—Urticaria—Carbamazepine—epilepsy syndrome	0.000562	0.000676	CcSEcCtD
Ceftibuten—Vomiting—Levetiracetam—epilepsy syndrome	0.000561	0.000675	CcSEcCtD
Ceftibuten—Headache—Midazolam—epilepsy syndrome	0.00056	0.000674	CcSEcCtD
Ceftibuten—Pruritus—Felbamate—epilepsy syndrome	0.000559	0.000673	CcSEcCtD
Ceftibuten—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000559	0.000673	CcSEcCtD
Ceftibuten—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000559	0.000673	CcSEcCtD
Ceftibuten—Diarrhoea—Diazepam—epilepsy syndrome	0.000559	0.000673	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000559	0.000673	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000557	0.00339	CbGpPWpGaD
Ceftibuten—Rash—Levetiracetam—epilepsy syndrome	0.000556	0.00067	CcSEcCtD
Ceftibuten—Dermatitis—Levetiracetam—epilepsy syndrome	0.000556	0.000669	CcSEcCtD
Ceftibuten—Asthenia—Zonisamide—epilepsy syndrome	0.000555	0.000669	CcSEcCtD
Ceftibuten—Agranulocytosis—Topiramate—epilepsy syndrome	0.000554	0.000667	CcSEcCtD
Ceftibuten—Dry mouth—Valproic Acid—epilepsy syndrome	0.000554	0.000667	CcSEcCtD
Ceftibuten—Agitation—Pregabalin—epilepsy syndrome	0.000553	0.000666	CcSEcCtD
Ceftibuten—Headache—Levetiracetam—epilepsy syndrome	0.000553	0.000665	CcSEcCtD
Ceftibuten—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00055	0.000662	CcSEcCtD
Ceftibuten—Dizziness—Vigabatrin—epilepsy syndrome	0.000549	0.000661	CcSEcCtD
Ceftibuten—Pruritus—Zonisamide—epilepsy syndrome	0.000548	0.000659	CcSEcCtD
Ceftibuten—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000546	0.000657	CcSEcCtD
Ceftibuten—Flatulence—Gabapentin—epilepsy syndrome	0.000544	0.000654	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000543	0.00331	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000543	0.00331	CbGpPWpGaD
Ceftibuten—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000543	0.000654	CcSEcCtD
Ceftibuten—Urticaria—Lamotrigine—epilepsy syndrome	0.000543	0.000654	CcSEcCtD
Ceftibuten—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000543	0.000654	CcSEcCtD
Ceftibuten—Nausea—Propofol—epilepsy syndrome	0.000542	0.000653	CcSEcCtD
Ceftibuten—Vomiting—Fosphenytoin—epilepsy syndrome	0.000541	0.000652	CcSEcCtD
Ceftibuten—Diarrhoea—Felbamate—epilepsy syndrome	0.000541	0.000651	CcSEcCtD
Ceftibuten—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00054	0.00065	CcSEcCtD
Ceftibuten—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00054	0.00065	CcSEcCtD
Ceftibuten—Dysgeusia—Gabapentin—epilepsy syndrome	0.00054	0.00065	CcSEcCtD
Ceftibuten—Dizziness—Diazepam—epilepsy syndrome	0.00054	0.00065	CcSEcCtD
Ceftibuten—Rash—Fosphenytoin—epilepsy syndrome	0.000537	0.000646	CcSEcCtD
Ceftibuten—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000536	0.000646	CcSEcCtD
Ceftibuten—Haemoglobin—Topiramate—epilepsy syndrome	0.000536	0.000645	CcSEcCtD
Ceftibuten—Asthenia—Clonazepam—epilepsy syndrome	0.000535	0.000644	CcSEcCtD
Ceftibuten—Headache—Fosphenytoin—epilepsy syndrome	0.000533	0.000642	CcSEcCtD
Ceftibuten—Haemorrhage—Topiramate—epilepsy syndrome	0.000533	0.000642	CcSEcCtD
Ceftibuten—Asthenia—Phenytoin—epilepsy syndrome	0.000532	0.00064	CcSEcCtD
Ceftibuten—Nausea—Midazolam—epilepsy syndrome	0.000531	0.000639	CcSEcCtD
Ceftibuten—Diarrhoea—Zonisamide—epilepsy syndrome	0.00053	0.000638	CcSEcCtD
Ceftibuten—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000529	0.000637	CcSEcCtD
Ceftibuten—Pruritus—Clonazepam—epilepsy syndrome	0.000528	0.000635	CcSEcCtD
Ceftibuten—Vomiting—Vigabatrin—epilepsy syndrome	0.000528	0.000635	CcSEcCtD
Ceftibuten—Pruritus—Phenytoin—epilepsy syndrome	0.000524	0.000631	CcSEcCtD
Ceftibuten—Nausea—Levetiracetam—epilepsy syndrome	0.000524	0.000631	CcSEcCtD
Ceftibuten—Rash—Vigabatrin—epilepsy syndrome	0.000523	0.00063	CcSEcCtD
Ceftibuten—Dizziness—Felbamate—epilepsy syndrome	0.000523	0.000629	CcSEcCtD
Ceftibuten—Dermatitis—Vigabatrin—epilepsy syndrome	0.000523	0.000629	CcSEcCtD
Ceftibuten—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000521	0.000628	CcSEcCtD
Ceftibuten—Convulsion—Pregabalin—epilepsy syndrome	0.000521	0.000628	CcSEcCtD
Ceftibuten—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000521	0.000627	CcSEcCtD
Ceftibuten—Headache—Vigabatrin—epilepsy syndrome	0.00052	0.000626	CcSEcCtD
Ceftibuten—Vomiting—Diazepam—epilepsy syndrome	0.000519	0.000625	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000518	0.00315	CbGpPWpGaD
Ceftibuten—Anorexia—Valproic Acid—epilepsy syndrome	0.000518	0.000623	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000517	0.00315	CbGpPWpGaD
Ceftibuten—Rash—Diazepam—epilepsy syndrome	0.000515	0.00062	CcSEcCtD
Ceftibuten—Dermatitis—Diazepam—epilepsy syndrome	0.000515	0.00062	CcSEcCtD
Ceftibuten—Dizziness—Zonisamide—epilepsy syndrome	0.000512	0.000616	CcSEcCtD
Ceftibuten—Headache—Diazepam—epilepsy syndrome	0.000512	0.000616	CcSEcCtD
Ceftibuten—Diarrhoea—Clonazepam—epilepsy syndrome	0.00051	0.000614	CcSEcCtD
Ceftibuten—Asthenia—Carbamazepine—epilepsy syndrome	0.000507	0.000611	CcSEcCtD
Ceftibuten—Agitation—Gabapentin—epilepsy syndrome	0.000507	0.00061	CcSEcCtD
Ceftibuten—Diarrhoea—Phenytoin—epilepsy syndrome	0.000507	0.00061	CcSEcCtD
Ceftibuten—Nausea—Fosphenytoin—epilepsy syndrome	0.000506	0.000609	CcSEcCtD
Ceftibuten—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000504	0.000607	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000504	0.00307	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000504	0.00307	CbGpPWpGaD
Ceftibuten—Erythema multiforme—Topiramate—epilepsy syndrome	0.000504	0.000607	CcSEcCtD
Ceftibuten—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000504	0.000606	CcSEcCtD
Ceftibuten—Vomiting—Felbamate—epilepsy syndrome	0.000503	0.000605	CcSEcCtD
Ceftibuten—Dry mouth—Pregabalin—epilepsy syndrome	0.000501	0.000603	CcSEcCtD
Ceftibuten—Pruritus—Carbamazepine—epilepsy syndrome	0.0005	0.000602	CcSEcCtD
Ceftibuten—Rash—Felbamate—epilepsy syndrome	0.000499	0.0006	CcSEcCtD
Ceftibuten—Dermatitis—Felbamate—epilepsy syndrome	0.000498	0.0006	CcSEcCtD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000498	0.00303	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000497	0.00302	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000497	0.00302	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000497	0.00302	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000497	0.00302	CbGpPWpGaD
Ceftibuten—Headache—Felbamate—epilepsy syndrome	0.000495	0.000596	CcSEcCtD
Ceftibuten—Dizziness—Clonazepam—epilepsy syndrome	0.000493	0.000594	CcSEcCtD
Ceftibuten—Nausea—Vigabatrin—epilepsy syndrome	0.000493	0.000593	CcSEcCtD
Ceftibuten—Vomiting—Zonisamide—epilepsy syndrome	0.000492	0.000592	CcSEcCtD
Ceftibuten—Insomnia—Valproic Acid—epilepsy syndrome	0.000491	0.000591	CcSEcCtD
Ceftibuten—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000491	0.000591	CcSEcCtD
Ceftibuten—Asthenia—Lamotrigine—epilepsy syndrome	0.00049	0.00059	CcSEcCtD
Ceftibuten—Dizziness—Phenytoin—epilepsy syndrome	0.00049	0.00059	CcSEcCtD
Ceftibuten—Rash—Zonisamide—epilepsy syndrome	0.000488	0.000587	CcSEcCtD
Ceftibuten—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000488	0.000587	CcSEcCtD
Ceftibuten—Dermatitis—Zonisamide—epilepsy syndrome	0.000488	0.000587	CcSEcCtD
Ceftibuten—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000487	0.000587	CcSEcCtD
Ceftibuten—Nausea—Diazepam—epilepsy syndrome	0.000485	0.000584	CcSEcCtD
Ceftibuten—Headache—Zonisamide—epilepsy syndrome	0.000485	0.000584	CcSEcCtD
Ceftibuten—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000484	0.000583	CcSEcCtD
Ceftibuten—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000484	0.000583	CcSEcCtD
Ceftibuten—Pruritus—Lamotrigine—epilepsy syndrome	0.000484	0.000582	CcSEcCtD
Ceftibuten—Somnolence—Valproic Acid—epilepsy syndrome	0.000483	0.000581	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000481	0.00293	CbGpPWpGaD
Ceftibuten—Chills—Topiramate—epilepsy syndrome	0.000478	0.000576	CcSEcCtD
Ceftibuten—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000478	0.000576	CcSEcCtD
Ceftibuten—Convulsion—Gabapentin—epilepsy syndrome	0.000478	0.000575	CcSEcCtD
Ceftibuten—Vomiting—Clonazepam—epilepsy syndrome	0.000474	0.000571	CcSEcCtD
Ceftibuten—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000472	0.000568	CcSEcCtD
Ceftibuten—Vomiting—Phenytoin—epilepsy syndrome	0.000471	0.000567	CcSEcCtD
Ceftibuten—Rash—Clonazepam—epilepsy syndrome	0.00047	0.000566	CcSEcCtD
Ceftibuten—Dermatitis—Clonazepam—epilepsy syndrome	0.00047	0.000566	CcSEcCtD
Ceftibuten—Nausea—Felbamate—epilepsy syndrome	0.00047	0.000565	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000469	0.000565	CcSEcCtD
Ceftibuten—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000469	0.000564	CcSEcCtD
Ceftibuten—Fatigue—Valproic Acid—epilepsy syndrome	0.000468	0.000564	CcSEcCtD
Ceftibuten—Anorexia—Pregabalin—epilepsy syndrome	0.000468	0.000563	CcSEcCtD
Ceftibuten—Dizziness—Carbamazepine—epilepsy syndrome	0.000468	0.000563	CcSEcCtD
Ceftibuten—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000468	0.000563	CcSEcCtD
Ceftibuten—Headache—Clonazepam—epilepsy syndrome	0.000467	0.000563	CcSEcCtD
Ceftibuten—Rash—Phenytoin—epilepsy syndrome	0.000467	0.000562	CcSEcCtD
Ceftibuten—Dermatitis—Phenytoin—epilepsy syndrome	0.000467	0.000562	CcSEcCtD
Ceftibuten—Rash—Oxcarbazepine—epilepsy syndrome	0.000465	0.000559	CcSEcCtD
Ceftibuten—Constipation—Valproic Acid—epilepsy syndrome	0.000464	0.000559	CcSEcCtD
Ceftibuten—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000464	0.000559	CcSEcCtD
Ceftibuten—Headache—Phenytoin—epilepsy syndrome	0.000464	0.000559	CcSEcCtD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000462	0.00281	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000462	0.00281	CbGpPWpGaD
Ceftibuten—Headache—Oxcarbazepine—epilepsy syndrome	0.000462	0.000556	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000461	0.00281	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000461	0.00281	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000461	0.00281	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000461	0.00281	CbGpPWpGaD
Ceftibuten—Nausea—Zonisamide—epilepsy syndrome	0.00046	0.000553	CcSEcCtD
Ceftibuten—Dry mouth—Gabapentin—epilepsy syndrome	0.000459	0.000553	CcSEcCtD
Ceftibuten—Flatulence—Topiramate—epilepsy syndrome	0.000457	0.000551	CcSEcCtD
Ceftibuten—Dysgeusia—Topiramate—epilepsy syndrome	0.000455	0.000547	CcSEcCtD
Ceftibuten—Dizziness—Lamotrigine—epilepsy syndrome	0.000452	0.000544	CcSEcCtD
Ceftibuten—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.00045	0.000542	CcSEcCtD
Ceftibuten—Vomiting—Carbamazepine—epilepsy syndrome	0.00045	0.000541	CcSEcCtD
Ceftibuten—Rash—Carbamazepine—epilepsy syndrome	0.000446	0.000537	CcSEcCtD
Ceftibuten—Dermatitis—Carbamazepine—epilepsy syndrome	0.000446	0.000536	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000444	0.000535	CcSEcCtD
Ceftibuten—Insomnia—Pregabalin—epilepsy syndrome	0.000444	0.000535	CcSEcCtD
Ceftibuten—Nausea—Clonazepam—epilepsy syndrome	0.000443	0.000533	CcSEcCtD
Ceftibuten—Headache—Carbamazepine—epilepsy syndrome	0.000443	0.000533	CcSEcCtD
Ceftibuten—Paraesthesia—Pregabalin—epilepsy syndrome	0.000441	0.000531	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000441	0.00268	CbGpPWpGaD
Ceftibuten—Nausea—Phenytoin—epilepsy syndrome	0.00044	0.00053	CcSEcCtD
Ceftibuten—Dyspnoea—Pregabalin—epilepsy syndrome	0.000438	0.000527	CcSEcCtD
Ceftibuten—Nausea—Oxcarbazepine—epilepsy syndrome	0.000438	0.000527	CcSEcCtD
Ceftibuten—Somnolence—Pregabalin—epilepsy syndrome	0.000437	0.000526	CcSEcCtD
Ceftibuten—Vomiting—Lamotrigine—epilepsy syndrome	0.000435	0.000523	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000434	0.00264	CbGpPWpGaD
Ceftibuten—Urticaria—Valproic Acid—epilepsy syndrome	0.000432	0.000519	CcSEcCtD
Ceftibuten—Rash—Lamotrigine—epilepsy syndrome	0.000431	0.000519	CcSEcCtD
Ceftibuten—Dermatitis—Lamotrigine—epilepsy syndrome	0.000431	0.000518	CcSEcCtD
Ceftibuten—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000429	0.000517	CcSEcCtD
Ceftibuten—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000429	0.000517	CcSEcCtD
Ceftibuten—Anorexia—Gabapentin—epilepsy syndrome	0.000429	0.000517	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000429	0.00261	CbGpPWpGaD
Ceftibuten—Ceftriaxone—ALB—epilepsy syndrome	0.000428	0.0855	CrCbGaD
Ceftibuten—Headache—Lamotrigine—epilepsy syndrome	0.000428	0.000515	CcSEcCtD
Ceftibuten—Decreased appetite—Pregabalin—epilepsy syndrome	0.000427	0.000514	CcSEcCtD
Ceftibuten—Agitation—Topiramate—epilepsy syndrome	0.000427	0.000514	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000424	0.00051	CcSEcCtD
Ceftibuten—Fatigue—Pregabalin—epilepsy syndrome	0.000423	0.00051	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000422	0.00257	CbGpPWpGaD
Ceftibuten—Nausea—Carbamazepine—epilepsy syndrome	0.00042	0.000506	CcSEcCtD
Ceftibuten—Constipation—Pregabalin—epilepsy syndrome	0.00042	0.000506	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000409	0.00249	CbGpPWpGaD
Ceftibuten—Insomnia—Gabapentin—epilepsy syndrome	0.000407	0.00049	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000407	0.00248	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000406	0.00247	CbGpPWpGaD
Ceftibuten—Nausea—Lamotrigine—epilepsy syndrome	0.000406	0.000489	CcSEcCtD
Ceftibuten—Paraesthesia—Gabapentin—epilepsy syndrome	0.000404	0.000487	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000403	0.00245	CbGpPWpGaD
Ceftibuten—Convulsion—Topiramate—epilepsy syndrome	0.000402	0.000484	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000402	0.000483	CcSEcCtD
Ceftibuten—Dyspnoea—Gabapentin—epilepsy syndrome	0.000401	0.000483	CcSEcCtD
Ceftibuten—Somnolence—Gabapentin—epilepsy syndrome	0.0004	0.000482	CcSEcCtD
Ceftibuten—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.0004	0.000482	CcSEcCtD
Ceftibuten—Dyspepsia—Gabapentin—epilepsy syndrome	0.000396	0.000477	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000393	0.00239	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000393	0.00239	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000392	0.00239	CbGpPWpGaD
Ceftibuten—Decreased appetite—Gabapentin—epilepsy syndrome	0.000391	0.000471	CcSEcCtD
Ceftibuten—Urticaria—Pregabalin—epilepsy syndrome	0.00039	0.00047	CcSEcCtD
Ceftibuten—Asthenia—Valproic Acid—epilepsy syndrome	0.00039	0.000469	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000389	0.000468	CcSEcCtD
Ceftibuten—Fatigue—Gabapentin—epilepsy syndrome	0.000388	0.000467	CcSEcCtD
Ceftibuten—Body temperature increased—Pregabalin—epilepsy syndrome	0.000388	0.000467	CcSEcCtD
Ceftibuten—Abdominal pain—Pregabalin—epilepsy syndrome	0.000388	0.000467	CcSEcCtD
Ceftibuten—Dry mouth—Topiramate—epilepsy syndrome	0.000386	0.000465	CcSEcCtD
Ceftibuten—Constipation—Gabapentin—epilepsy syndrome	0.000385	0.000464	CcSEcCtD
Ceftibuten—Pruritus—Valproic Acid—epilepsy syndrome	0.000384	0.000463	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000377	0.0023	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000377	0.00229	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000377	0.00229	CbGpPWpGaD
Ceftibuten—Cefalotin—ALB—epilepsy syndrome	0.000375	0.0749	CrCbGaD
Ceftibuten—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000372	0.000447	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000368	0.000443	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000365	0.00222	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000365	0.00222	CbGpPWpGaD
Ceftibuten—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000362	0.000436	CcSEcCtD
Ceftibuten—Anorexia—Topiramate—epilepsy syndrome	0.000361	0.000435	CcSEcCtD
Ceftibuten—Dizziness—Valproic Acid—epilepsy syndrome	0.000359	0.000432	CcSEcCtD
Ceftibuten—Urticaria—Gabapentin—epilepsy syndrome	0.000358	0.000431	CcSEcCtD
Ceftibuten—Body temperature increased—Gabapentin—epilepsy syndrome	0.000356	0.000429	CcSEcCtD
Ceftibuten—Abdominal pain—Gabapentin—epilepsy syndrome	0.000356	0.000429	CcSEcCtD
Ceftibuten—Asthenia—Pregabalin—epilepsy syndrome	0.000352	0.000424	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.00035	0.00213	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000349	0.00213	CbGpPWpGaD
Ceftibuten—Pruritus—Pregabalin—epilepsy syndrome	0.000347	0.000418	CcSEcCtD
Ceftibuten—Vomiting—Valproic Acid—epilepsy syndrome	0.000345	0.000416	CcSEcCtD
Ceftibuten—Insomnia—Topiramate—epilepsy syndrome	0.000343	0.000412	CcSEcCtD
Ceftibuten—Rash—Valproic Acid—epilepsy syndrome	0.000342	0.000412	CcSEcCtD
Ceftibuten—Dermatitis—Valproic Acid—epilepsy syndrome	0.000342	0.000412	CcSEcCtD
Ceftibuten—Headache—Valproic Acid—epilepsy syndrome	0.00034	0.00041	CcSEcCtD
Ceftibuten—Paraesthesia—Topiramate—epilepsy syndrome	0.00034	0.00041	CcSEcCtD
Ceftibuten—Dyspnoea—Topiramate—epilepsy syndrome	0.000338	0.000407	CcSEcCtD
Ceftibuten—Somnolence—Topiramate—epilepsy syndrome	0.000337	0.000405	CcSEcCtD
Ceftibuten—Diarrhoea—Pregabalin—epilepsy syndrome	0.000336	0.000404	CcSEcCtD
Ceftibuten—Dyspepsia—Topiramate—epilepsy syndrome	0.000333	0.000401	CcSEcCtD
Ceftibuten—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000332	0.000399	CcSEcCtD
Ceftibuten—Decreased appetite—Topiramate—epilepsy syndrome	0.000329	0.000396	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000327	0.000394	CcSEcCtD
Ceftibuten—Fatigue—Topiramate—epilepsy syndrome	0.000327	0.000393	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000325	0.00198	CbGpPWpGaD
Ceftibuten—Dizziness—Pregabalin—epilepsy syndrome	0.000325	0.000391	CcSEcCtD
Ceftibuten—Constipation—Topiramate—epilepsy syndrome	0.000324	0.00039	CcSEcCtD
Ceftibuten—Asthenia—Gabapentin—epilepsy syndrome	0.000323	0.000389	CcSEcCtD
Ceftibuten—Nausea—Valproic Acid—epilepsy syndrome	0.000323	0.000388	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.00032	0.00195	CbGpPWpGaD
Ceftibuten—Pruritus—Gabapentin—epilepsy syndrome	0.000319	0.000384	CcSEcCtD
Ceftibuten—Vomiting—Pregabalin—epilepsy syndrome	0.000312	0.000376	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000312	0.0019	CbGpPWpGaD
Ceftibuten—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.00031	0.000373	CcSEcCtD
Ceftibuten—Rash—Pregabalin—epilepsy syndrome	0.00031	0.000373	CcSEcCtD
Ceftibuten—Dermatitis—Pregabalin—epilepsy syndrome	0.000309	0.000372	CcSEcCtD
Ceftibuten—Diarrhoea—Gabapentin—epilepsy syndrome	0.000308	0.000371	CcSEcCtD
Ceftibuten—Headache—Pregabalin—epilepsy syndrome	0.000308	0.00037	CcSEcCtD
Ceftibuten—Urticaria—Topiramate—epilepsy syndrome	0.000301	0.000362	CcSEcCtD
Ceftibuten—Body temperature increased—Topiramate—epilepsy syndrome	0.000299	0.000361	CcSEcCtD
Ceftibuten—Abdominal pain—Topiramate—epilepsy syndrome	0.000299	0.000361	CcSEcCtD
Ceftibuten—Dizziness—Gabapentin—epilepsy syndrome	0.000298	0.000358	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000297	0.00181	CbGpPWpGaD
Ceftibuten—Nausea—Pregabalin—epilepsy syndrome	0.000292	0.000351	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.00029	0.00176	CbGpPWpGaD
Ceftibuten—Vomiting—Gabapentin—epilepsy syndrome	0.000286	0.000345	CcSEcCtD
Ceftibuten—Rash—Gabapentin—epilepsy syndrome	0.000284	0.000342	CcSEcCtD
Ceftibuten—Dermatitis—Gabapentin—epilepsy syndrome	0.000284	0.000341	CcSEcCtD
Ceftibuten—Headache—Gabapentin—epilepsy syndrome	0.000282	0.00034	CcSEcCtD
Ceftibuten—Hypersensitivity—Topiramate—epilepsy syndrome	0.000279	0.000336	CcSEcCtD
Ceftibuten—Asthenia—Topiramate—epilepsy syndrome	0.000272	0.000327	CcSEcCtD
Ceftibuten—Pruritus—Topiramate—epilepsy syndrome	0.000268	0.000323	CcSEcCtD
Ceftibuten—Nausea—Gabapentin—epilepsy syndrome	0.000267	0.000322	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000265	0.00161	CbGpPWpGaD
Ceftibuten—Diarrhoea—Topiramate—epilepsy syndrome	0.000259	0.000312	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000253	0.00154	CbGpPWpGaD
Ceftibuten—Dizziness—Topiramate—epilepsy syndrome	0.000251	0.000302	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000246	0.0015	CbGpPWpGaD
Ceftibuten—SLC15A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000246	0.0015	CbGpPWpGaD
Ceftibuten—Vomiting—Topiramate—epilepsy syndrome	0.000241	0.00029	CcSEcCtD
Ceftibuten—Rash—Topiramate—epilepsy syndrome	0.000239	0.000288	CcSEcCtD
Ceftibuten—Dermatitis—Topiramate—epilepsy syndrome	0.000239	0.000287	CcSEcCtD
Ceftibuten—Headache—Topiramate—epilepsy syndrome	0.000237	0.000286	CcSEcCtD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000235	0.00143	CbGpPWpGaD
Ceftibuten—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000228	0.00139	CbGpPWpGaD
Ceftibuten—Nausea—Topiramate—epilepsy syndrome	0.000225	0.000271	CcSEcCtD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000208	0.00127	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000206	0.00126	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.0002	0.00122	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000193	0.00118	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000191	0.00117	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000185	0.00113	CbGpPWpGaD
Ceftibuten—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000125	0.000761	CbGpPWpGaD
Ceftibuten—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000116	0.000706	CbGpPWpGaD
